Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Biotime Inc (BTX)

2.73 0.09 (3.41%)

01-23 16:00

Open:

2.61

Pre. Close:

2.64

High:

2.77

Low:

2.61

Volume:

823,083

Market Cap:

346M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

2.771 - 2.788

2.788 - 2.804

Low:

2.582 - 2.601

2.601 - 2.619

Close:

2.7 - 2.729

2.729 - 2.756

Technical analysis  (as of: 2018-01-23 4:22:05 PM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 3.27     One year: 3.82

Support:

Support1: 2.37    Support2: 2.10

Resistance:

Resistance1: 2.80    Resistance2: 3.27

Pivot:

2.61

Moving Averages:

MA(5): 2.66     MA(20): 2.52

MA(100): 2.59     MA(250): 2.89

MACD:

MACD(12,26): 0.07     Signal(12,26,9): 0.06

%K %D:

%K(14,3): 80.95     %D(3): 79.21

RSI:

RSI(14): 64.34

52-Week:

High: 3.62  Low: 2.1  Change(%): -16.9

Average Vol(K):

3-Month: 43540  10-Days 36744

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
BTX has closed below upper band by 25.8%. Bollinger Bands are 25.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 11 Dec 2012 15:00:02 GMT
AtmanCo Inc.

Wed, 16 Aug 2017 13:02:38 GMT
AtmanCo Announces Signature of a Letter of Intent for the Acquisition of ...

Tue, 03 Oct 2017 12:56:15 GMT
AtmanCo Completes the Acquisition of VuduMobile and Signed a Letter of Intent ...

Thu, 25 May 2017 19:52:30 GMT
AtmanCo Announces Revenue Growth of $2.5 Million for Its First Quarter of 2017

Thu, 09 Jun 2016 13:30:00 GMT
AtmanCo Announces Signature of a Letter of Intent for the Acquisition of ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

126.87

Shares Float (M)

112.98

% Held by Insiders

10.90

% Held by Institutions

39.60

Shares Short (K)

6713

Shares Short Prior Month (K)

6770

Stock Financials

EPS

-0.180

EPS Est. Current Year

0.150

EPS Est. Next Year

-0.290

EPS Est. Next Quarter

-0.080

Forward EPS

-0.310

Book Value (p.s.)

1.690

PEG Ratio

Profit Margin

Operating Margin

-1195.54

Return on Assets (ttm)

25.4

Return on Equity (ttm)

29.5

Qtrly Rev. Growth

12.6

Gross Profit (p.s.)

0.027

Sales Per Share

EBITDA (p.s.)

-0.308

Qtrly Earnings Growth

-54.10

Operating Cash Flow (M)

-33.69

Levered Free Cash Flow (M)

-22.92

atoplab.com

Valuation

P/E

-15.19

P/E Growth Ratio

0.04

P/BV

1.62

P/S

11566314496.00

P/CF

-10.30

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.